Live Breaking News & Updates on Processa Pharma|Page 6
Stay updated with breaking news from Processa pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch KENILWORTH (NJ) (dpa-AFX) - Today s Daily Dose brings you news about Nektar s collaboration with Merck; Pfizer initiating a refractory multiple myeloma study; Processa Pharma s strategic financing; and vTv Therapeutics initiation of a phase 1 multiple ascending dose study of HPP737. Read on. 1. Nektar Teams Up With Merck Nektar Therapeutics (NKTR) has entered into a clinical trial collaboration and supply agreement with Merck (MRK) for a Phase 2/3 study of Bempegaldesleukin in combination with KEYTRUDA for first-line treatment of patients with metastatic or unresectable recurrent squamous cell carcinoma of the head and neck. ....